Home > Qtrly Results > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
Quarterly Results Analysis [Dec2023]

ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results

ASTRAZENECA PHARMA INDIA Quarterly Results

Standalone Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
UnAudited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
UnAudited
Mar2022
Audited
Revenues ₹306 Cr ₹311 Cr ₹295 Cr ₹285 Cr ₹250 Cr ₹236 Cr ₹232 Cr ₹232 Cr
Expenses ₹291 Cr ₹258 Cr ₹228 Cr ₹225 Cr ₹213 Cr ₹195 Cr ₹204 Cr ₹194 Cr
Operating Income ₹15 Cr ₹53 Cr ₹67 Cr ₹60 Cr ₹37 Cr ₹41 Cr ₹28 Cr ₹38 Cr
Other Income ₹10 Cr ₹8 Cr ₹8 Cr ₹8 Cr ₹7 Cr ₹7 Cr ₹4 Cr ₹4 Cr
Interest ₹1 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹3 Cr ₹5 Cr ₹4 Cr
Profit Before Tax ₹20 Cr ₹73 Cr ₹71 Cr ₹23 Cr ₹39 Cr ₹44 Cr ₹27 Cr ₹37 Cr
Profit After Tax ₹16 Cr ₹52 Cr ₹54 Cr ₹17 Cr ₹29 Cr ₹33 Cr ₹20 Cr ₹28 Cr
EPS ₹6.32 ₹20.95 ₹21.54 ₹6.91 ₹11.72 ₹13.03 ₹8.06 ₹11.19
Industry Peers & Returns1W1M1Y
ASTRAZENECA PHARMA INDIA -0.3% -8% 53%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%

ASTRAZENECA PHARMA INDIA Quarterly Revenues

Revenues
Q-o-Q

-1.70 %

Y-o-Y

22.41 %

Quarters Revenues % Change
Dec2023 ₹306 Cr
-1.70
Sep2023 ₹311 Cr
5.28
Jun2023 ₹295 Cr
3.78
Mar2023 ₹285 Cr
13.97
Dec2022 ₹250 Cr
5.79
Sep2022 ₹236 Cr
1.63
Jun2022 ₹232 Cr
0.16
Mar2022 ₹232 Cr -

ASTRAZENECA PHARMA INDIA Quarterly Operating Profit

Operating Profit
Q-o-Q

-71.46 %

Y-o-Y

-58.85 %

Quarters Operating Profit % Change
Dec2023 ₹15 Cr
-71.46
Sep2023 ₹53 Cr
-21.54
Jun2023 ₹67 Cr
12.36
Mar2023 ₹60 Cr
63.57
Dec2022 ₹37 Cr
-10.16
Sep2022 ₹41 Cr
45.63
Jun2022 ₹28 Cr
-26.33
Mar2022 ₹38 Cr -
Operating Margins
Q-o-Q

-70.99 %

Y-o-Y

-66.42 %

Quarters Operating Margin% % Change
Dec2023 4.92%
-70.99
Sep2023 16.96%
-25.48
Jun2023 22.76%
8.28
Mar2023 21.02%
43.48
Dec2022 14.65%
-15.07
Sep2022 17.25%
43.27
Jun2022 12.04%
-26.45
Mar2022 16.37% -

ASTRAZENECA PHARMA INDIA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-69.83 %

Y-o-Y

-46.09 %

Quarters Profit After Tax % Change
Dec2023 ₹16 Cr
-69.83
Sep2023 ₹52 Cr
-2.77
Jun2023 ₹54 Cr
211.85
Mar2023 ₹17 Cr
-41.07
Dec2022 ₹29 Cr
-10.01
Sep2022 ₹33 Cr
61.57
Jun2022 ₹20 Cr
-27.98
Mar2022 ₹28 Cr -
PAT Margins
Q-o-Q

-69.30 %

Y-o-Y

-55.92 %

Quarters PAT Margin(%) % Change
Dec2023 5.17 %
-69.30
Sep2023 16.84 %
-7.62
Jun2023 18.23 %
200.33
Mar2023 6.07 %
-48.25
Dec2022 11.73 %
-14.94
Sep2022 13.79 %
58.87
Jun2022 8.68 %
-28.03
Mar2022 12.06 % -

ASTRAZENECA PHARMA INDIA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-69.83 %

Y-o-Y

-46.08 %

Quarters EPS % Change
Dec2023 ₹6.32
-69.83
Sep2023 ₹20.95
-2.74
Jun2023 ₹21.54
211.72
Mar2023 ₹6.91
-41.04
Dec2022 ₹11.72
-10.05
Sep2022 ₹13.03
61.66
Jun2022 ₹8.06
-27.97
Mar2022 ₹11.19 -

You may also like the below Video Courses